Intrahepatic cholangiocarcinoma
Conditions
Interventions
Gold Standard:Clinical outcome
Index test:Accurate 
judgments 
model 
based 
on 
clinical 
of 
cancer 
combined 
with 
Bayes 
and 
Sponsors
Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Patients with biliary malignancies treated by radical surgery (R0 and R1 resection); (2) The pathological examination results clearly diagnosed as gallbladder cancer or cholangiocarcinoma; (3) No other malignant tumors; (4) No other anti-tumor treatments, such as radiotherapy and chemotherapy, were performed before and during the operation.
Exclusion criteria
Exclusion criteria: (1) Pathological examination is for patients with other types other than gallbladder cancer or cholangiocarcinoma, or whose pathological diagnosis is not clear; (2) Patients with non-primary gallbladder cancer or cholangiocarcinoma; (3) Patients with other malignant tumors; (4) Patients with distant metastasis (M1 stage); (5) Patients with gallbladder cancer or cholangiocarcinoma who have not undergone radical resection; (6) Patients who lack a clear record of the number of positive lymph nodes and the location of lymph node metastasis; (7) Incomplete follow-up data after surgery; (8) The patient died within 30 days after the operation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SEN, SPE, ACC, AUC of ROC, PPV, NPV, etc.; | — |
Countries
China
Contacts
Public ContactSi Yu
Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Outcome results
None listed